GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nuformix PLC (LSE:NFX) » Definitions » Total Receivables

Nuformix (LSE:NFX) Total Receivables : £0.26 Mil (As of Sep. 2022)


View and export this data going back to 2015. Start your Free Trial

What is Nuformix Total Receivables?

Nuformix's Total Receivables for the quarter that ended in Sep. 2022 was £0.26 Mil.


Nuformix Total Receivables Historical Data

The historical data trend for Nuformix's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nuformix Total Receivables Chart

Nuformix Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
Total Receivables
Get a 7-Day Free Trial 0.16 0.15 0.04 0.02 0.17

Nuformix Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.05 0.17 0.26 0.13

Nuformix Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables


Nuformix Total Receivables Related Terms

Thank you for viewing the detailed overview of Nuformix's Total Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Nuformix (LSE:NFX) Business Description

Traded in Other Exchanges
Address
60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR
Nuformix PLC is a pharmaceutical development company. It operates in the field of pharmaceutical development targeting unmet medical needs in fibrosis and oncology via drug repurposing. Its pipeline products include NXP001, NXP002, and NXP004. Geographically, the company operates only in the UK.

Nuformix (LSE:NFX) Headlines

From GuruFocus

4 Independent Oil Drillers To Acquire Today

By Vatalyst.com Vatalyst.com 03-09-2012

Newfield Exploration Company (NFX) EVP and COO Gary D Packer sells 15,000 Shares

By GuruFocus Research GuruFocus Editor 12-13-2010

Newfield's Production Plans: Everything You Need to Know

By Sarfaraz A. Khan Sarfaraz A. Khan 12-27-2013

Newfield Exploration Company (NFX) EVP and COO Gary D Packer sells 10,000 Shares

By GuruFocus Research GuruFocus Editor 12-29-2009